[ad_1]
This has paved the way for a mass vaccination campaign in the second most populous country in the world, according to Reuters.
India’s Information and Broadcasting Minister Prakash Javadekar said on Saturday that the vaccine had received the green light on Friday.
According to Reuters, this is the first Covid-19 vaccine approved for emergency use in India.
After the United States, India has the highest number of people infected with the coronavirus. The number of identified patients in the country has already exceeded one crore and three lakh. About one and a half lakhs of patients have died.
The Indian government plans to vaccinate 300 million people in India in the next six to eight months. In this case, priority will be given to seriously ill patients and doctors, nurses, policemen and those fighting the epidemic, authorities said. The government will also bear the cost of these vaccines.
Before the official start of vaccination, the exercise was conducted on Saturday at 259 centers in 117 districts across the country and the Union Territory. If vaccines are being distributed as planned, what are the obstacles to vaccination, they are being examined in the exercise.
At least three more vaccines are awaiting approval in India, Javadekar said. These are Kovacin from local company Bharat Biotech, Zykov-D from Zydus Cadillac and Sputnik-V from Russia.
The UK was the first country in the world to approve the Oxford-AstraZeneca coronavirus vaccine on December 30. Later, the vaccine was approved in Argentina.
AstraZeneca says it will create three billion doses of vaccines for everyone in the next year. The Serum Institute of India (SII) has participated in the production of this vaccine in India.
The approval of the expert panel on the approval of the Oxford vaccine in India
The Indian version of the Oxford-AstraZeneca ticker is called ‘Kovishield’, according to Anandabazar.
IBS Director Umesh Saligram told PTI that they have 75 million doses of the Oxford-AstraZeneca vaccine and expect stocks to reach 100 million by the first week of January.
Oxford vaccine can be stored at room temperature in the refrigerator; As a result, the vaccine is relatively easy to reach anywhere in the world.
But Pfizer’s coronavirus vaccine must be stored at minus 60 degrees Celsius and the modern vaccine at minus 20 degrees Celsius, which is not possible in a normal refrigerator.
There are two doses of Oxford Ticker for everyone. There will be a 28-day interval between the two doses. SII’s Covishield will be sold to the Indian government at around Rs 250 per dose and Rs 1,000 on the market, according to Reuters.
[ad_2]
